ECTE Financial Facts
Derivative warrant liability gain (loss): 3.68MInterest expense: -133.06K
See Full Income Statement
Common stock: 116.36K
Total other assets: 485.62K
See Full Balance Sheet
Echo Therapeutics (ECTE) Earnings
|
Expand Research on ECTE
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +9.5% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -14.1% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8/12/16 | Q216 | -$0.82 | N/A | N/A | N/A | N/A | N/A |  | | Details | |
| 8/8/13 | Q213 | -$0.51 | -$0.81 | +$0.30 | $22.56M | $10M | N/A | | | Details | |
| 5/20/16 | Q116 | -$0.23 | N/A | N/A | N/A | N/A | N/A | | | Details | |
| 11/19/14 | Q314 | -$0.43 | N/A | N/A | $19.11M | $22.56M | N/A | | | Details | |
| 3/27/14 | Q413 | -$0.36 | -$0.40 | +$0.04 | N/A | $20K | N/A | | | Details | |
| 5/9/14 | Q114 | -$0.23 | -$0.31 | +$0.08 | $19.11K | $20K | N/A | | | Details | |
| 8/14/15 | Q215 | -$0.97 | N/A | N/A | N/A | N/A | N/A | | | Details | |
8/14/14  |
Q214 | -$0.31 | -$0.23 | -$0.08 | $19.1M | $22.56M | N/A | | | Details |
